Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Cardiology Reports
Metadata
Title
Health Disparities Across the Continuum of ASCVD Risk
Publication date
05-07-2022
Published in
Current Cardiology Reports / Issue 9/2022
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-022-01736-y

Other articles of this Issue 9/2022

Current Cardiology Reports 9/2022 Go to the issue

Global Cardiovascular Health (L Sperling and D Gaita, Section Editors)

HIV and Global Cardiovascular Health

Myocardial Disease (A Abbate and M Merlo, Section Editors)

Emerging Genotype–Phenotype Associations in Dilated Cardiomyopathy

Cardiovascular Genomics (KG Aragam, Section Editor)

Use of Polygenic Risk Scores for Coronary Heart Disease in Ancestrally Diverse Populations

Myocardial Disease (A Abbate and M Merlo, Section Editors)

Cardiovascular Damage in COVID-19: What We Know Two Years Later

Cardio-Oncology (LA Baldassarre, Section Editor)

Advanced Echocardiographic Techniques in Cardio-Oncology: the Role for Early Detection of Cardiotoxicity

Global Cardiovascular Health (L Sperling and D Gaita, Section Editors)

Aspirin for Primary Prevention of Cardiovascular Diseases: “WALTZ” with the Evidence

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits